Author:
Nakamura Kogenta,Ikawa Kazuro,Nishikawa Genya,Kobayashi Ikuo,Tobiume Motoi,Sugie Miho,Muramatsu Hiroyuki,Morinaga Shingo,Kajikawa Keishi,Watanabe Masahito,Kanao Kent,Onita Tetsushu,Morikawa Norifumi
Subject
Infectious Diseases,Pharmacology (medical),Microbiology (medical)
Reference25 articles.
1. Flumarin (flomoxef for injection) prescribing information;Shionogi,2019
2. Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia;Partina;Jpn J Antibiot,2016
3. Antimicrobial activity of flomoxef against Enterobacteriaceae including extended spectrum beta-lactamases-producing strains isolated at Ramathibodi Hospital: a 1000-bed tertiary care hospital in Bangkok, Thailand;Santanirand;J Infect Dis Ther,2018
4. Evaluation of antibacterial activities of flomoxef against ESBL producing Enterobacteriaceae analyzed by Monte Carlo simulation;Ito;Jpn J Antibiot,2013
5. In vitro activity of flomoxef against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Korea;Jung;Diagn Microbiol Infect Dis,2019
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献